First Trust Advisors
CGEM icon

First Trust Advisors’s Cullinan Oncology CGEM Stock Holding History

First Trust Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-136,887
Closed -$2.39M – 2385
2024
Q2 		$2.39M Buy
136,887
+41,116
+43% +$875K ﹤0.01% 1625
2024
Q1 		$1.63M Buy
95,771
+2,896
+3% +$44.7K ﹤0.01% 1818
2023
Q4 		$946K Buy
92,875
+2,305
+3% +$20.4K ﹤0.01% 1982
2023
Q3 		$820K Buy
+90,570
New +$943K ﹤0.01% 2020

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

First Trust Advisors's CGEM Position: Q3 2024 in Review

First Trust Advisors sold out of Cullinan Oncology (CGEM) in Q3 2024, closing a stake of 136,887 shares — an estimated $2.39M sold.

First Trust Advisors first reported a position in CGEM in Q3 2023 and held it in 4 quarters. The position peaked at $2.39M in Q2 2024. 137 funds tracked by Wall St. Rank hold CGEM as of Q3 2024.

  • First Trust Advisors reported no remaining Cullinan Oncology position as of Q3 2024 after selling out during the quarter.
  • First Trust Advisors sold 136,887 Cullinan Oncology shares in Q3 2024, an estimated $2.39M.
  • First Trust Advisors first reported a position in Cullinan Oncology in Q3 2023 and held it in 4 quarters.
  • First Trust Advisors's Cullinan Oncology position peaked at $2.39M in Q2 2024.
  • 137 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2024.

Based on First Trust Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.